title: Use of preferentially replicating bacteria for the treatment of cancer.
authors.affiliation: Vion Pharmaceuticals Inc., New Haven, Connecticut 06511, USA. msznol@vionpharm.com
authors.forename: M
authors.initials: M
authors.lastname: Sznol
authors.forename: S L
authors.initials: SL
authors.lastname: Lin
authors.forename: D
authors.initials: D
authors.lastname: Bermudes
authors.forename: L M
authors.initials: LM
authors.lastname: Zheng
authors.forename: I
authors.initials: I
authors.lastname: King
mesh_terms: D000818:Animals; D001691:Biological Therapy; D002455:Cell Division; D005818:Genetic Engineering; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D012475:Salmonella / Q000235:genetics / Q000502:physiology*